Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: Clinical and Pharmacogenomic results from SWOG S0124. - Lara,P.N.; Natale,R.; Crowley,J. (J Clin Oncol, 2009)